FindTrial
Sign In

Neoadjuvant significance of preoperative synchronous radiotherapy in patients with advanced esophageal squamous cell carcinoma

Neoadjuvant significance of preoperative synchronous radiotherapy in patients with advanced esophageal squamous cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060062
Enrollment
Unknown
Registered
2022-05-16
Start date
2022-05-06
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local advanced esophageal squamous cell carcinoma

Interventions

case series:None

Sponsors

Department of Thoracic Surgery, Army Specialty Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: From January 2012 to December 2020, all patients with esophageal cancer who were diagnosed as esophageal squamous cell carcinoma and received neoadjuvant therapy combined with minimally invasive esophageal cancer resection were admitted to our center.

Exclusion criteria

Exclusion criteria: 1. Patients with R1 or R2 resection; 2. Patients in stage T4; 3. Patients aged >18 years and <80 years; 4. Patients participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
progression free survival;—

Secondary

MeasureTime frame
surgical time;blood loss;number of lymph nodes;incidence of postoperative complication;—

Countries

China

Contacts

Public ContactGuo Wei

Department of Thoracic Surgery, Army Specialty Medical Center

gyguowei@hotmail.com+86 13527323568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026